.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Serving leading biopharmaceutical companies globally:

Julphar
Argus Health
Teva
Johnson and Johnson
Covington
Accenture
Federal Trade Commission
Dow
Healthtrust
UBS

Pharmaceutical companies with the most 'New Patient Population' drugs

This chart shows the companies which have received the most New Patient Population exclusivities in the past five years.

New Patient Populations are one of the categories for which the FDA grants three years of exclusivity for 'New Clinical Investigations.'

Alternate categories worth of three years of protection include identifying a New Combination, New Product, or New Strength.

The companies with the most New Patient Populations drugs are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot